Cargando…

Current status of liver transplantation for non‐B non‐C liver cirrhosis and hepatocellular carcinoma

Recently, non‐B non‐C chronic liver diseases, including alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), have markedly increased worldwide. Liver transplantation (LT) is an effective curative therapy for hepatocellular carcinoma (HCC) as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishio, Takahiro, Ito, Takashi, Hata, Koichiro, Taura, Kojiro, Hatano, Etsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831911/ https://www.ncbi.nlm.nih.gov/pubmed/36643372 http://dx.doi.org/10.1002/ags3.12612

Ejemplares similares

Current status of preoperative risk assessment for posthepatectomy liver failure in patients with hepatocellular carcinoma
por: Nishio, Takahiro, et al.
Publicado: (2023)

Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients
por: Ito, Takashi, et al.
Publicado: (2020)

Acute coronary syndrome after liver transplantation in a young primary biliary cholangitis recipient with dyslipidemia: a case report
por: Yao, Siyuan, et al.
Publicado: (2022)

Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis
por: Taura, Kojiro, et al.
Publicado: (2016)

En bloc excision of giant polycystic liver with hepatic cava and its auto‐transplant caval reconstruction as a safe surgical procedure for liver transplantation
por: Hata, Koichiro, et al.
Publicado: (2022)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
por: Nishio, Takahiro, et al.
Publicado: (2022)

A Conceptual Classification of Resectability for Hepatocellular Carcinoma
por: Yoh, Tomoaki, et al.
Publicado: (2022)

Correction: A Conceptual Classification of Resectability for Hepatocellular Carcinoma
por: Yoh, Tomoaki, et al.
Publicado: (2022)

Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies
por: Iwaisako, Keiko, et al.
Publicado: (2014)

Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics
por: Itohara, Kotaro, et al.
Publicado: (2022)

Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3
por: Kasai, Yosuke, et al.
Publicado: (2017)

Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
por: Dooghaie Moghadam, Arash, et al.
Publicado: (2020)

Living donor liver transplantation for adult Budd Chiari syndrome – Resection without replacement of retrohepatic IVC: A case report
por: Sabra, Tarek Abdelazeem, et al.
Publicado: (2017)

The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation
por: Tajima, Tetsuya, et al.
Publicado: (2022)

Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study
por: Nakamura, Naohiko, et al.
Publicado: (2019)

Propionic Acid, Induced in Gut by an Inulin Diet, Suppresses Inflammation and Ameliorates Liver Ischemia and Reperfusion Injury in Mice
por: Kawasoe, Junya, et al.
Publicado: (2022)

Long-Term Outcomes of Hepatic Resection versus Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Propensity Score-Matching Study
por: Kaido, Toshimi, et al.
Publicado: (2015)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

Nutrition in Liver Cirrhosis and Transplantation—Current State and Knowledge Gaps
por: Raman, Maitreyi, et al.
Publicado: (2020)

Properdin inhibition ameliorates hepatic ischemia/reperfusion injury without interfering with liver regeneration in mice
por: Kusakabe, Jiro, et al.
Publicado: (2023)

Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival
por: Nomura, Aya, et al.
Publicado: (2020)

Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review
por: Miwa, Takao, et al.
Publicado: (2020)

Unusual Ileocecal Ulcers after Liver Transplantation for Hepatitis B Cirrhosis and Hepatocellular Carcinoma
por: He, Kang, et al.
Publicado: (2022)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Current status of laparoscopic liver resection for hepatocellular carcinoma
por: Guro, Hanisah, et al.
Publicado: (2016)

Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
por: Tajima, Tetsuya, et al.
Publicado: (2023)

Patients with Cirrhosis of Liver Operated for Non-transplant Surgery: A Retrospective Analysis
por: Subramanian, Kishore Kumar Kuduva, et al.
Publicado: (2019)

Relationship of α-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis
por: TAURA, NAOTA, et al.
Publicado: (2012)

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
por: Safaei, Akram, et al.
Publicado: (2016)

Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
por: Ueda, Yoshihide, et al.
Publicado: (2017)

Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
por: Raff, Evan J., et al.
Publicado: (2015)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

Structure and surgical dissection layers of the bare area of the liver
por: Ishii, Takamichi, et al.
Publicado: (2020)

Current status of liver transplantation for cholangiocarcinoma
por: Twohig, Patrick, et al.
Publicado: (2022)

Management of chronic liver diseases and cirrhosis: current status and future directions
por: Xu, Jing-Hang, et al.
Publicado: (2020)

The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
por: Zhang, Qing, et al.
Publicado: (2012)

Detection of MAGE‐4 Protein in the Sera of Patients with Hepatitis‐C Virus‐associated Hepatocellular Carcinoma and Liver Cirrhosis
por: Tsuzurahara, Shin‐ichi, et al.
Publicado: (1997)

Liver Cirrhosis and Hepatocellular Carcinoma Diagnosed from Chylothorax: A Case Report
por: Ito, Kenta, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Liver Cirrhosis
por: Boicean, Adrian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_opesnu67l08qpsqnvv3bm238o3